Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?
Forbes
Saturday, July 19, 2014 - 9:23am
tags:
GSK's phase III study of trametinib and dabrafenib combo shows survival benefit compared to vemurafenib
Pharmabiz
Saturday, July 19, 2014 - 9:20am
tags:
trametinib, GSK, vemurafenib, dabrafenib, melanoma
Strides Arcolab invests in Oncobiologics Inc
India TV News, India
Saturday, July 19, 2014 - 9:15am
tags:
Strides Arcolab, Oncobiologics
Rexahn Pharmaceuticals Provides Update on Phase I Supinoxin Trial in Cancer Patients with Solid Tumors
Pharmiweb
Saturday, July 19, 2014 - 9:05am
tags:
Supinoxin, Rexahn
It’s a Good Time to Be a Drugmaker: Why J&J Is Beating Wall Street
Wall St Cheat Sheet
Saturday, July 19, 2014 - 8:54am
tags:
JNJ
Gilead: 50% Upside From Here
Seeking Alpha
Saturday, July 19, 2014 - 8:51am
tags:
Gilead Sciences
StemCells, Inc. Announces Closing of $20 Million Offering
Yahoo/Globe Newswire
Saturday, July 19, 2014 - 8:47am
tags:
StemCells
Why the Market is Wrong About Baxter Stock
Motley Fool
Saturday, July 19, 2014 - 8:45am
tags:
Baxter
An Open Letter To Janet Yellen: Is There A Biotech Bubble?
Forbes
Saturday, July 19, 2014 - 8:44am
tags:
Biotech VCs bet $1.8B in a colossal Q2
Fierce Biotech
Saturday, July 19, 2014 - 12:05am
tags:
biotech, venture capital
Arena Stock Rises With Expected Jump In Belviq Sales
Seeking Alpha
Saturday, July 19, 2014 - 12:03am
tags:
Arena Pharmaceuticals, Belviq
Drugmaker Valeant touts Bausch + Lomb growth to Allergan investors
Yahoo/Reuters
Saturday, July 19, 2014 - 12:02am
tags:
Valeant Pharmaceuticals, M&A, Bausch & Lomb, Allergan
AbbVie: Shire Buy More Than Just Taxes
Yahoo/Investors Business Daily
Saturday, July 19, 2014 - 12:01am
tags:
AbbVie, Shire, tax inversions
Will Congress Scuttle the AbbVie-Shire Merger?
FOX Business
Friday, July 18, 2014 - 2:24pm
tags:
US Congress, M&A, AbbVie, Shire
AstraZeneca unveils plans for 'see-through' labs in Cambridge; drug giant hopes layout will encourage collaboration
Telegraph, UK
Friday, July 18, 2014 - 11:58am
tags:
AstraZeneca, R&D
Flu Drug Fighting Resistant Strains to Seek U.S. Approval
Bloomberg
Friday, July 18, 2014 - 11:23am
tags:
FDA, influenza, Medivector, favipiravir, Fujifilm
Sage soars after banking $90M in an up-sized IPO
Fierce Biotech
Friday, July 18, 2014 - 11:20am
tags:
SAGE Therapeutics, CNS, IPOs
Ackman to Allergan shareholders: Valeant's offer won't last forever
Fierce Pharma
Friday, July 18, 2014 - 11:14am
tags:
Allergan, Bill Ackman, Valeant Pharmaceuticals, M&A
Gentiva Gets Alternative Offer After Kindred’s Hostile Bids
Bloomberg
Friday, July 18, 2014 - 11:12am
tags:
Gentiva Health Services, Kindred Healthcare, M&A
[video] Tax implications of AbbVie-Shire
CNBC
Friday, July 18, 2014 - 11:09am
tags:
AbbVie, Shire, M&A, taxes, tax inversions

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.